184 related articles for article (PubMed ID: 16883019)
1. Acquisition settings for PET of 124I administered simultaneously with therapeutic amounts of 131I.
Lubberink M; van Schie A; de Jong HW; van Dongen GA; Teule GJ
J Nucl Med; 2006 Aug; 47(8):1375-81. PubMed ID: 16883019
[TBL] [Abstract][Full Text] [Related]
2. Optimized 124I PET dosimetry protocol for radioiodine therapy of differentiated thyroid cancer.
Jentzen W; Freudenberg L; Eising EG; Sonnenschein W; Knust J; Bockisch A
J Nucl Med; 2008 Jun; 49(6):1017-23. PubMed ID: 18483099
[TBL] [Abstract][Full Text] [Related]
3. Three-dimensional positron emission tomography imaging with 124I and 86Y.
Vandenberghe S
Nucl Med Commun; 2006 Mar; 27(3):237-45. PubMed ID: 16479243
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I.
Pettinato C; Monari F; Nanni C; Allegri V; Marcatili S; Civollani S; Cima S; Spezi E; Mazzarotto R; Fanti S
Q J Nucl Med Mol Imaging; 2012 Dec; 56(6):509-14. PubMed ID: 23358403
[TBL] [Abstract][Full Text] [Related]
6. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
[TBL] [Abstract][Full Text] [Related]
7. Patient-specific dosimetry for 131I thyroid cancer therapy using 124I PET and 3-dimensional-internal dosimetry (3D-ID) software.
Sgouros G; Kolbert KS; Sheikh A; Pentlow KS; Mun EF; Barth A; Robbins RJ; Larson SM
J Nucl Med; 2004 Aug; 45(8):1366-72. PubMed ID: 15299063
[TBL] [Abstract][Full Text] [Related]
8. Prediction of absorbed dose to normal organs in thyroid cancer patients treated with 131I by use of 124I PET and 3-dimensional internal dosimetry software.
Kolbert KS; Pentlow KS; Pearson JR; Sheikh A; Finn RD; Humm JL; Larson SM
J Nucl Med; 2007 Jan; 48(1):143-9. PubMed ID: 17204711
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer.
Sgouros G; Hobbs RF; Atkins FB; Van Nostrand D; Ladenson PW; Wahl RL
Eur J Nucl Med Mol Imaging; 2011 May; 38 Suppl 1(Suppl 1):S41-7. PubMed ID: 21484384
[TBL] [Abstract][Full Text] [Related]
10. 124-iodine positron emission tomography/computed tomography dosimetry in pediatric patients with differentiated thyroid cancer.
Freudenberg LS; Jentzen W; Marlowe RJ; Koska WW; Luster M; Bockisch A
Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):690-3. PubMed ID: 18058605
[TBL] [Abstract][Full Text] [Related]
11. Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.
Kobayashi M; Wakabayashi H; Kojima H; Konishi T; Okuda K; Yoneyama H; Kayano D; Tobisaka M; Tsushima H; Onoguchi M; Kawai K; Kinuya S
Hell J Nucl Med; 2013; 16(3):175-80. PubMed ID: 24137580
[TBL] [Abstract][Full Text] [Related]
12. Comparison of 2-dimensional and 3-dimensional acquisition for 18F-FDG PET oncology studies performed on an LSO-based scanner.
Lodge MA; Badawi RD; Gilbert R; Dibos PE; Line BR
J Nucl Med; 2006 Jan; 47(1):23-31. PubMed ID: 16391183
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of 124I PET/CT in patients with differentiated thyroid cancer.
Capoccetti F; Criscuoli B; Rossi G; Ferretti F; Manni C; Brianzoni E
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):536-45. PubMed ID: 19910907
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET.
Hobbs RF; Jentzen W; Bockisch A; Sgouros G
Q J Nucl Med Mol Imaging; 2013 Mar; 57(1):79-91. PubMed ID: 23474639
[TBL] [Abstract][Full Text] [Related]
15. Pretherapeutic dosimetry in patients affected by metastatic thyroid cancer using 124I PET/CT sequential scans for 131I treatment planning.
Pettinato C; Spezi E; Nanni C; Grassetto G; Monari F; Allegri V; Civollani S; Cima S; Zagni P; Mazzarotto R; Colletti PM; Rubello D; Fanti S
Clin Nucl Med; 2014 Aug; 39(8):e367-74. PubMed ID: 24978332
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic value of 124I-PET in patients with differentiated thyroid cancer.
Phan HT; Jager PL; Paans AM; Plukker JT; Sturkenboom MG; Sluiter WJ; Wolffenbuttel BH; Dierckx RA; Links TP
Eur J Nucl Med Mol Imaging; 2008 May; 35(5):958-65. PubMed ID: 18175115
[TBL] [Abstract][Full Text] [Related]
17. Iodine-124 PET dosimetry in differentiated thyroid cancer: recovery coefficient in 2D and 3D modes for PET(/CT) systems.
Jentzen W; Weise R; Kupferschläger J; Freudenberg L; Brandau W; Bares R; Burchert W; Bockisch A
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):611-23. PubMed ID: 17929014
[TBL] [Abstract][Full Text] [Related]
18. Assessment of lesion response in the initial radioiodine treatment of differentiated thyroid cancer using 124I PET imaging.
Jentzen W; Hoppenbrouwers J; van Leeuwen P; van der Velden D; van de Kolk R; Poeppel TD; Nagarajah J; Brandau W; Bockisch A; Rosenbaum-Krumme S
J Nucl Med; 2014 Nov; 55(11):1759-65. PubMed ID: 25332440
[TBL] [Abstract][Full Text] [Related]
19. Dose-Response Relationship in Differentiated Thyroid Cancer Patients Undergoing Radioiodine Treatment Assessed by Means of 124I PET/CT.
Wierts R; Brans B; Havekes B; Kemerink GJ; Halders SG; Schaper NN; Backes WH; Mottaghy FM; Jentzen W
J Nucl Med; 2016 Jul; 57(7):1027-32. PubMed ID: 26917706
[TBL] [Abstract][Full Text] [Related]
20. A lesion detection observer study comparing 2-dimensional versus fully 3-dimensional whole-body PET imaging protocols.
Lartizien C; Kinahan PE; Comtat C
J Nucl Med; 2004 Apr; 45(4):714-23. PubMed ID: 15073270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
